Skip to NavigationSkip to content

Pharmafile - Business Services News

Giliad's Yesarta becomes second FDA-approved CAR T treatment and AstraZeneca admits efficacy data for an acquired cancer drug was fabricated. Check...
It’s always crunch time for regulatory operations. Whether you’re managing plans and documents for an upcoming IND or producing routine product...
Childhood obesity has increased ten-fold, China to finally accept overseas trial data and GSK rated worst UK company for governance in new report....
Following on from the popularity of our previous free  webinar sessions, Pharmafocus is once...
French police raid Merck KGaA HQ and 57% of EU-approved cancer drugs revealed to show no real clinical benefit. Check out the week's ten most popular...
Super malaria outbreak, 19 patients deaths in Intercept's trial, a new triple-threat HIV treatment and EMA warnings of drug delays following its...
Inside this issue you can find exclusive comments from ABPI Chief Executive Mike Thompson on the release of Sir John Bell's Life Sciences Industrial...
FDA approves first-ever cancer biosimilar and digital app, but implements another immunotherapy trial hold, this time on Roche. Checl out this week's...
New CEO for Teva, massive global staff cuts for Lilly, and 'pharma bro' Martin Shkreli finally heads to jail - check out the week's ten most popular...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches